Eqwal Roeselare SA
Eqwal Roeselare reported total assets of 659,062 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Mar 2026).
The score of Eqwal Roeselare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -70 % Total assets -60 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eqwal Roeselare's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 16 Mar 2026
- Year ended 30 Sep 2024filed on 17 Apr 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Eqwal Roeselare's financial analysis
- Solvency31.9%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eqwal Roeselare
Eqwal Roeselare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0450.255.093
- VAT number
- BE0450255093
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 07 Jun 1993
- Registered office
- 9041 Ghent
- Latest accounts
- 2025 · filed on 16 Mar 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Eqwal Roeselare (SA) has been based in Ghent since 1993, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 150,221 € and equity of 210,469 €; its revenue is not published. Its solvency stands at 31.9%, below the median of its sector (47.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eqwal Roeselare
Companies in the same business, of comparable size and area, outside its group.
- GP Audiologie Retail sale of medical and orthopaedic goods Anthisnes · balance sheet 439,670 €
- Arterix Retail sale of medical and orthopaedic goods Destelbergen · balance sheet 9,206 €
- Bandagisterie der Kinderen Retail sale of medical and orthopaedic goods Kasterlee · balance sheet 667,222 €
- Kineso Retail sale of medical and orthopaedic goods Mechelen · balance sheet 669,287 €
- Euromax Retail sale of medical and orthopaedic goods Mechelen · balance sheet 627,637 €
- T.W. Medic Retail sale of medical and orthopaedic goods Ramillies · balance sheet 627,360 €
- B-Unisound Retail sale of medical and orthopaedic goods Montigny-le-Tilleul · balance sheet 707,064 €
- Veranneman Antwerpen Retail sale of medical and orthopaedic goods Antwerp · balance sheet 608,259 €
Frequently asked questions about Eqwal Roeselare
What is the revenue of Eqwal Roeselare?
Eqwal Roeselare files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eqwal Roeselare?
In Belgium, the VAT number is the company number prefixed with BE: BE0450255093 for Eqwal Roeselare, if the company is VAT-registered. Its company number (CBE) is 0450.255.093.
Where is the registered office of Eqwal Roeselare?
According to the CBE register, the registered office of Eqwal Roeselare is in 9041 Ghent.
What is the equity of Eqwal Roeselare?
At the close of the 2025 financial year, the equity of Eqwal Roeselare amounts to 210,469 €, a solvency of 31.9% of total assets.
Who manages Eqwal Roeselare?
The register lists 2 active mandates at Eqwal Roeselare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eqwal Roeselare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →